Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation

NCT00171522 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00171522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00171522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2005
Completion date
September 30, 2005
Enrollment
52
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

constipation